Israel has the fourth-highest per capita rate of leukemia fatalities worldwide. In the United States, the blood cancer kills more than 24,000 Americans annually.
According to the Israel Cancer Research Fund, a majority of leukemia treatments today focus on chemotherapy, steroid drugs and stem-cell transplants. Ben-Gurion University of the Negev (BGU) scientist Dr. Roi Gazit has been conducting intensive research in the hunt for more effective, targeted leukemia treatments.
Gazit explains, “Immune therapies and stem-cell treatments offer great advantages, but there are too many options to choose from. At Ben-Gurion University, our research models will help to better specify which treatment may suit a specific type, and even sub-type, of the disease.